Gut Microbiome Predicts Nivolumab Efficacy in Gastric Cancer? Gut Microbiome Predicts Nivolumab Efficacy in Gastric Cancer?

Preliminary data suggest that the diversity of the gut microbiome could potentially predict nivolumab response for patients with gastric cancer.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news